Literature DB >> 21809851

Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.

Fengtian Xue1, James M Kraus, Kristin Jansen Labby, Haitao Ji, Jan Mataka, Guoyao Xia, Huiying Li, Silvia L Delker, Linda J Roman, Pavel Martásek, Thomas L Poulos, Richard B Silverman.   

Abstract

We report an efficient synthetic route to chiral pyrrolidine inhibitors of neuronal nitric oxide synthase (nNOS) and crystal structures of the inhibitors bound to nNOS and to endothelial NOS. The new route enables versatile structure-activity relationship studies on the pyrrolidine-based scaffold, which can be beneficial for further development of nNOS inhibitors. The X-ray crystal structures of five new fluorine-containing inhibitors bound to nNOS provide insights into the effect of the fluorine atoms on binding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809851      PMCID: PMC3174355          DOI: 10.1021/jm200411j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Authors:  Kristin Jansen Labby; Fengtian Xue; James M Kraus; Haitao Ji; Jan Mataka; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-02-07       Impact factor: 3.641

2.  Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.

Authors:  Graham R Lawton; Hantamalala Ralay Ranaivo; Laura K Chico; Haitao Ji; Fengtian Xue; Pavel Martásek; Linda J Roman; D Martin Watterson; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2009-02-14       Impact factor: 3.641

Review 3.  Role of nitric oxide in Parkinson's disease.

Authors:  Li Zhang; Valina L Dawson; Ted M Dawson
Journal:  Pharmacol Ther       Date:  2005-07-07       Impact factor: 12.310

4.  Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Huiying Li; Silvia L Delker; Jianguo Fang; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2010-10-13       Impact factor: 15.419

5.  An Alkoxide Anion Triggered tert-Butyloxycarbonyl Group Migration. Mechanism and Application.

Authors:  Fengtian Xue; Richard B Silverman
Journal:  Tetrahedron Lett       Date:  2010-05-05       Impact factor: 2.415

6.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

7.  Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.

Authors:  Fengtian Xue; Jianguo Fang; William W Lewis; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2009-11-22       Impact factor: 2.823

8.  General method for the palladium-catalyzed allylation of aliphatic alcohols.

Authors:  Anthony R Haight; Eric J Stoner; Matthew J Peterson; Vandana K Grover
Journal:  J Org Chem       Date:  2003-10-17       Impact factor: 4.354

9.  Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.

Authors:  P J Norris; H J Waldvogel; R L Faull; D R Love; P C Emson
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

10.  Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.

Authors:  M A Dorheim; W R Tracey; J S Pollock; P Grammas
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

  10 in total
  4 in total

1.  Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Authors:  Kristin Jansen Labby; Fengtian Xue; James M Kraus; Haitao Ji; Jan Mataka; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-02-07       Impact factor: 3.641

2.  High yielding allylation of a chiral secondary alcohol containing base sensitive functional groups.

Authors:  James M Kraus; Hunter C Gits; Richard B Silverman
Journal:  Tetrahedron Lett       Date:  2012-03-14       Impact factor: 2.415

Review 3.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

4.  Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.

Authors:  Huiying Li; Fengtian Xue; James M Kraus; Haitao Ji; Kristin Jansen Labby; Jan Mataka; Silvia L Delker; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-12-22       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.